JP2000510844A5 - - Google Patents

Download PDF

Info

Publication number
JP2000510844A5
JP2000510844A5 JP1997540997A JP54099797A JP2000510844A5 JP 2000510844 A5 JP2000510844 A5 JP 2000510844A5 JP 1997540997 A JP1997540997 A JP 1997540997A JP 54099797 A JP54099797 A JP 54099797A JP 2000510844 A5 JP2000510844 A5 JP 2000510844A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1997540997A
Other languages
English (en)
Japanese (ja)
Other versions
JP2000510844A (ja
JP4105230B2 (ja
Filing date
Publication date
Priority claimed from US08/645,672 external-priority patent/US5762943A/en
Application filed filed Critical
Publication of JP2000510844A publication Critical patent/JP2000510844A/ja
Publication of JP2000510844A5 publication Critical patent/JP2000510844A5/ja
Application granted granted Critical
Publication of JP4105230B2 publication Critical patent/JP4105230B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP54099797A 1996-05-14 1997-05-08 モノホスホリルリピドaを用いてi型過敏症を治療する方法 Expired - Lifetime JP4105230B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/645,672 US5762943A (en) 1996-05-14 1996-05-14 Methods of treating type I hypersensitivity using monophosphoryl lipid A
US08/645,672 1996-05-14
PCT/US1997/007965 WO1997042947A1 (en) 1996-05-14 1997-05-08 Methods of treating type i hypersensitivity using monophosphoryl lipid a

Publications (3)

Publication Number Publication Date
JP2000510844A JP2000510844A (ja) 2000-08-22
JP2000510844A5 true JP2000510844A5 (cg-RX-API-DMAC10.html) 2004-11-25
JP4105230B2 JP4105230B2 (ja) 2008-06-25

Family

ID=24589990

Family Applications (1)

Application Number Title Priority Date Filing Date
JP54099797A Expired - Lifetime JP4105230B2 (ja) 1996-05-14 1997-05-08 モノホスホリルリピドaを用いてi型過敏症を治療する方法

Country Status (11)

Country Link
US (1) US5762943A (cg-RX-API-DMAC10.html)
EP (1) EP0914114B1 (cg-RX-API-DMAC10.html)
JP (1) JP4105230B2 (cg-RX-API-DMAC10.html)
AT (1) ATE249824T1 (cg-RX-API-DMAC10.html)
AU (1) AU3121497A (cg-RX-API-DMAC10.html)
CA (1) CA2252604C (cg-RX-API-DMAC10.html)
DE (1) DE69724970T2 (cg-RX-API-DMAC10.html)
DK (1) DK0914114T3 (cg-RX-API-DMAC10.html)
ES (1) ES2205231T3 (cg-RX-API-DMAC10.html)
PT (1) PT914114E (cg-RX-API-DMAC10.html)
WO (1) WO1997042947A1 (cg-RX-API-DMAC10.html)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4086928B2 (ja) * 1997-02-13 2008-05-14 大日本住友製薬株式会社 タイプ2ヘルパーt細胞型サイトカイン産生選択的抑制剤
GB9706957D0 (en) * 1997-04-05 1997-05-21 Smithkline Beecham Plc Formulation
GB9724531D0 (en) * 1997-11-19 1998-01-21 Smithkline Biolog Novel compounds
AU763770B2 (en) * 1998-07-14 2003-07-31 Wyeth Holdings Corporation Adjuvant and vaccine compositions containing monophosphoryl lipid A
WO2000016804A1 (en) * 1998-09-18 2000-03-30 Dynavax Technologies Corporation METHODS OF TREATING IgE-ASSOCIATED DISORDERS AND COMPOSITIONS FOR USE THEREIN
EP1671646A3 (en) * 1998-09-18 2007-08-29 Dynavax Technologies Corporation Methods of treating IgE-associated disorders and compositions for use therein
GB9820525D0 (en) * 1998-09-21 1998-11-11 Allergy Therapeutics Ltd Formulation
US6649170B1 (en) * 1999-05-12 2003-11-18 Statens Serum Institut Adjuvant combinations for immunization composition and vaccines
CZ20013916A3 (cs) * 1999-05-13 2002-06-12 American Cyanamid Company Adjuvantní kombinované prostředky
GB0000891D0 (en) * 2000-01-14 2000-03-08 Allergy Therapeutics Ltd Formulation
US20030105032A1 (en) * 2000-05-19 2003-06-05 Persing David H. Phophylactic and therapeutic treatment of infectious and other diseases with mono-and disaccharide-based compounds
US20030139356A1 (en) * 2001-05-18 2003-07-24 Persing David H. Prophylactic and therapeutic treatment of infectious and other diseases with mono- and disaccharide-based compounds
JP5004261B2 (ja) * 2000-05-19 2012-08-22 コリクサ コーポレイション 単糖類及び二糖類に基づく化合物を用いた感染症及び他の疾患の予防的並びに治療的な処置
US6787524B2 (en) 2000-09-22 2004-09-07 Tanox, Inc. CpG oligonucleotides and related compounds for enhancing ADCC induced by anti-IgE antibodies
BR0115271A (pt) * 2000-11-10 2005-12-13 Wyeth Corp Composição antigênica, método para incrementar a capacidade de uma composição antigênica em elicitar a resposta imunológica de um hospedeiro vertebrado, em elicitar linfócitos t citotóxicos em um hospedeiro vertebrado, em elicitar um efeito terapêutico ou profilático anti-câncer em um hospedeiro vertebrado, em moderar uma resposta alérgica em um hospedeiro vertebrado, e em prevenir ou tratar doença caracterizada por deposição amilóide em um hospedeiro vertebrado, e, formulação adjuvante
US20030031684A1 (en) * 2001-03-30 2003-02-13 Corixa Corporation Methods for the production of 3-O-deactivated-4'-monophosphoryl lipid a (3D-MLA)
RU2289410C2 (ru) * 2001-04-04 2006-12-20 Корикса Корпорейшн Профилактика и лечение инфекционных и других заболеваний с помощью соединений, основанных на моно- и дисахаридах
GB0120150D0 (en) * 2001-08-17 2001-10-10 Glaxosmithkline Biolog Sa Novel compounds
DE10359351A1 (de) 2003-12-16 2005-07-21 Merck Patent Gmbh DNA-Sequenz und rekombinante Herstellung von Gruppe-4 Majorallergenen aus Getreiden
US20060210590A1 (en) 2005-02-03 2006-09-21 Alk-Abello A/S Minor allergen control to increase safety of immunotherapy
PT2484375T (pt) 2006-09-26 2018-07-09 Infectious Disease Res Inst Composição para vacina contendo adjuvante sintético
EP2563390A4 (en) * 2010-04-30 2014-05-14 Allovate Llc METHOD AND ARTICLE FOR PREVENTING OR REDUCING THE RISK OF DEVELOPING A HYPERALGENIC IMMUNE SYSTEM
SG11201407586WA (en) 2012-05-16 2014-12-30 Immune Design Corp Vaccines for hsv-2
HK1214510A1 (zh) 2013-04-18 2016-07-29 Immune Design Corp. 用於癌症治疗的gla单一疗法
US9463198B2 (en) 2013-06-04 2016-10-11 Infectious Disease Research Institute Compositions and methods for reducing or preventing metastasis
CR20160369A (es) * 2014-01-21 2016-10-05 Immune Desing Corp Composiciones para uso en el tratamiento de afecciones alérgicas
US10688120B2 (en) 2015-05-01 2020-06-23 Nitto Denko Corporation Allergy vaccine composition

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0058021A3 (en) * 1981-02-06 1982-10-27 Beecham Group Plc Pharmaceutical compositions
US4436727A (en) * 1982-05-26 1984-03-13 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product
US4844894A (en) * 1984-07-12 1989-07-04 Ribi Immunochem Research Inc. Method of inhibiting the onset of septicemia and endotoxemia
US5244663A (en) * 1987-01-28 1993-09-14 Medibrevex Therapeutic method against allergy
KR900701304A (ko) * 1988-05-05 1990-12-01 루이즈 츄이 콜린스 에이미 사람 및/또는 동물용 알레르겐 탈감작제
US4912094B1 (en) * 1988-06-29 1994-02-15 Ribi Immunochem Research Inc. Modified lipopolysaccharides and process of preparation
US4990336A (en) * 1989-02-08 1991-02-05 Biosearch, Inc. Sustained release dosage form
JP2838800B2 (ja) * 1989-09-02 1998-12-16 株式会社林原生物化学研究所 減感作剤
US5286718A (en) * 1991-12-31 1994-02-15 Ribi Immunochem Research, Inc. Method and composition for ameliorating tissue damage due to ischemia and reperfusion
WO1993015766A1 (en) * 1992-02-10 1993-08-19 Seragen, Inc. Desensitization to specific allergens

Similar Documents

Publication Publication Date Title
JP2000508393A5 (cg-RX-API-DMAC10.html)
JP2000506989A5 (cg-RX-API-DMAC10.html)
JP2002500522A5 (cg-RX-API-DMAC10.html)
JP2001507774A5 (cg-RX-API-DMAC10.html)
JP2001504697A5 (cg-RX-API-DMAC10.html)
JP2000508275A5 (cg-RX-API-DMAC10.html)
JP2001503741A5 (cg-RX-API-DMAC10.html)
JP2001504009A5 (cg-RX-API-DMAC10.html)
JP2000509021A5 (cg-RX-API-DMAC10.html)
JP2000510735A5 (cg-RX-API-DMAC10.html)
JP2001503739A5 (cg-RX-API-DMAC10.html)
JP2001502689A5 (cg-RX-API-DMAC10.html)
JP2000509394A5 (cg-RX-API-DMAC10.html)
JP2000505491A5 (cg-RX-API-DMAC10.html)
JP2000509396A5 (cg-RX-API-DMAC10.html)
JP2001501584A5 (cg-RX-API-DMAC10.html)
JP2001500130A5 (cg-RX-API-DMAC10.html)
JP2001502371A5 (cg-RX-API-DMAC10.html)
JP2001507731A5 (cg-RX-API-DMAC10.html)
JP2000507281A5 (cg-RX-API-DMAC10.html)
JP2000514259A5 (cg-RX-API-DMAC10.html)
JP2000505445A5 (cg-RX-API-DMAC10.html)
JP2001502658A5 (cg-RX-API-DMAC10.html)
JP2000504610A5 (cg-RX-API-DMAC10.html)
JP2000515368A5 (cg-RX-API-DMAC10.html)